Xin-hua Xu

Xiaoxita, 443000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Analysis of cancer-specific survival in patients with metastatic colorectal cancer: A evidence-based medicine study.

Analysis of cancer-specific survival in patients with metastatic colorectal cancer: A evidence-based medicine study.

Journal: World journal of gastrointestinal surgery

Published: March 08, 2024

CDC Like Kinase 2 plays an oncogenic role in colorectal cancer via modulating the Wnt/β-catenin signaling.

CDC Like Kinase 2 plays an oncogenic role in colorectal cancer via modulating the Wnt/β-catenin signaling.

Journal: Neoplasma

Published: February 06, 2022

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma.

Journal: Frontiers in oncology

Published: January 21, 2020

Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy.

Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy.

Journal: Annals of translational medicine

Published: December 01, 2018

Cetuximab versus nimotuzumab for the treatment of advanced nasopharyngeal carcinoma: A network meta-analysis.

Cetuximab versus nimotuzumab for the treatment of advanced nasopharyngeal carcinoma: A network meta-analysis.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: September 28, 2017

Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis.

Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis.

Journal: SpringerPlus

Published: April 12, 2016

Combination treatment with antiEGFR monoclonal antibodies in advanced nasopharyngeal carcinoma : a meta-analysis.

Combination treatment with antiEGFR monoclonal antibodies in advanced nasopharyngeal carcinoma : a meta-analysis.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: February 09, 2016

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma.

Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma.

Journal: Saudi medical journal

Published: May 20, 2015

Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells.

Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells.

Journal: Technology in cancer research & treatment

Published: January 14, 2015

Study of the correlationship link between microRNAs and nasopharyngeal carcinoma.

Study of the correlationship link between microRNAs and nasopharyngeal carcinoma.

Journal: Saudi medical journal

Published: April 22, 2014

ShRNA targeting Bmi-1 sensitizes CD44⁺ nasopharyngeal cancer stem-like cells to radiotherapy.

ShRNA targeting Bmi-1 sensitizes CD44⁺ nasopharyngeal cancer stem-like cells to radiotherapy.

Journal: Oncology reports

Published: March 02, 2014

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer.

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer.

Journal: Cancer chemotherapy and pharmacology

Published: May 31, 2010

Showing 1-12 of 13

Last Updated: 09/26/2026